DK480489D0 - Anvendelse af pteridinforbindelser til forebyggelse af primaer og sekundaer resistens ved kemoterapi, og laegemidler indeholdende disse forbindelser - Google Patents

Anvendelse af pteridinforbindelser til forebyggelse af primaer og sekundaer resistens ved kemoterapi, og laegemidler indeholdende disse forbindelser

Info

Publication number
DK480489D0
DK480489D0 DK480489A DK480489A DK480489D0 DK 480489 D0 DK480489 D0 DK 480489D0 DK 480489 A DK480489 A DK 480489A DK 480489 A DK480489 A DK 480489A DK 480489 D0 DK480489 D0 DK 480489D0
Authority
DK
Denmark
Prior art keywords
compounds
group
pteridines
chemotherapy
pteridic
Prior art date
Application number
DK480489A
Other languages
English (en)
Other versions
DK480489A (da
Inventor
Armin Heckel
Joerg Lebsanft
Uwe Bamberger
Avner Ramu
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK480489D0 publication Critical patent/DK480489D0/da
Publication of DK480489A publication Critical patent/DK480489A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK480489A 1988-10-01 1989-09-29 Anvendelse af pteridinforbindelser til forebyggelse af primaer og sekundaer resistens ved kemoterapi, og laegemidler indeholdende disse forbindelser DK480489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (de) 1988-10-01 1988-10-01 Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
DK480489D0 true DK480489D0 (da) 1989-09-29
DK480489A DK480489A (da) 1990-04-02

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK480489A DK480489A (da) 1988-10-01 1989-09-29 Anvendelse af pteridinforbindelser til forebyggelse af primaer og sekundaer resistens ved kemoterapi, og laegemidler indeholdende disse forbindelser

Country Status (19)

Country Link
EP (1) EP0362645B1 (da)
JP (1) JPH02256676A (da)
KR (1) KR910006289A (da)
AT (1) ATE106728T1 (da)
AU (1) AU620645B2 (da)
DD (1) DD299062A5 (da)
DE (2) DE3833393A1 (da)
DK (1) DK480489A (da)
ES (1) ES2056174T3 (da)
FI (1) FI92699C (da)
HU (1) HU205761B (da)
IL (1) IL91814A (da)
MX (1) MX9203034A (da)
NO (1) NO175979C (da)
NZ (1) NZ230833A (da)
PT (1) PT91836B (da)
SU (1) SU1720491A3 (da)
UA (1) UA8028A1 (da)
ZA (1) ZA897414B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
ATE277929T1 (de) * 1998-12-28 2004-10-15 4 Aza Bioscience Nv Immunsuppressive wirkungen von pteridinderivaten
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
DE602004008304T2 (de) * 2003-09-12 2008-05-08 4 Aza Ip Nv Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha
PT1673092E (pt) * 2003-10-17 2007-11-23 4 Aza Ip Nv ''derivados de pteridina substituídos com heterociclos e sua utilização em terapia''
RU2447074C2 (ru) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
EP3097102B1 (en) 2015-03-04 2017-10-18 Gilead Sciences, Inc. Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
KR20160003575A (ko) 2015-11-09 2016-01-11 정민시 발전기용 동력전달장치
EP3507276B1 (en) 2016-09-02 2021-11-03 Gilead Sciences, Inc. Toll like receptor modulator compounds
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (da) * 1966-10-14
DE1617336C2 (de) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Arzneimittel gegen Angina pectoris
DE1795515A1 (de) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Herzwirksame Zubereitungen
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
AU4174989A (en) 1990-04-05
FI894615A (fi) 1990-04-02
IL91814A (en) 1994-02-27
FI894615A0 (fi) 1989-09-29
DE3833393A1 (de) 1990-04-05
SU1720491A3 (ru) 1992-03-15
JPH02256676A (ja) 1990-10-17
FI92699C (fi) 1994-12-27
PT91836A (pt) 1990-04-30
NO893879D0 (no) 1989-09-29
EP0362645A3 (de) 1992-03-25
UA8028A1 (uk) 1995-12-26
AU620645B2 (en) 1992-02-20
KR910006289A (ko) 1991-04-29
NO893879L (no) 1990-04-02
HUT52504A (en) 1990-07-28
ZA897414B (en) 1991-06-26
HU205761B (en) 1992-06-29
DD299062A5 (de) 1992-03-26
EP0362645B1 (de) 1994-06-08
IL91814A0 (en) 1990-06-10
NO175979C (no) 1995-01-11
ES2056174T3 (es) 1994-10-01
FI92699B (fi) 1994-09-15
PT91836B (pt) 1995-07-18
MX9203034A (es) 1992-07-01
EP0362645A2 (de) 1990-04-11
DE58907824D1 (de) 1994-07-14
NZ230833A (en) 1991-05-28
ATE106728T1 (de) 1994-06-15
DK480489A (da) 1990-04-02
NO175979B (no) 1994-10-03

Similar Documents

Publication Publication Date Title
DK480489D0 (da) Anvendelse af pteridinforbindelser til forebyggelse af primaer og sekundaer resistens ved kemoterapi, og laegemidler indeholdende disse forbindelser
IL68075A0 (en) Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them
ES8405782A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
DK0687253T3 (da) Hidtil ukendte 4-aminopyridiner, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse forbindelser
ES8707238A1 (es) Procedimiento para preparar pteridinas
IE821768L (en) Pyrrolidine derivatives
ES436160A1 (es) Procedimiento para preparar 1, 1-diaril-1-oxadiazol-alquila-minas.
ES456039A1 (es) Procedimiento para preparar derivados de indolizina.
ATE113030T1 (de) Hydroxyalkancarbonsäure-derivate und deren verwendung.
ATE35133T1 (de) N-substituierte (bis(hydroxymethyl)-methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ATE1672T1 (de) In 4-stellung substituierte 1-(aminoalkylamino)5,8-dihydroxy-anthrachinone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen dieser verbindungen.
ES468586A1 (es) Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas.
ES331427A1 (es) Procedimiento para la preparacion de nuevos compuestos heterociclicos condensados.
ES345993A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
ES394967A1 (es) Procedimiento para la preparacion de 3-alcohil-5-ariloxime-tilisoxazoles.
DK460080A (da) Fremgangsmaade til fremstilling af substituerede 3,6-bis(aminoalkoxy) aridiner
ES345991A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
ES8403853A1 (es) Procedimiento para la fabricacion de nuevos derivados aminoalquil naftalenicos.
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
HUT64940A (en) Tetrahydro-naphtaline derivatives and methods for producing these compounds and for preparing pharmaceutical preparatives containing them
ES304710A1 (es) Procedimiento para la preparaciën de 1,3,5-triacinas
ES451655A1 (es) Un procedimiento para la preparacion de derivados de pirimi-dina.
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
GB880334A (en) New hydrazinium compounds, their production and pharmaceutical compositions containing them
TH9137EX (th) สารประกอบเททราไซคลิคชนิดใหม่ซึ่งมีฤทธิ์ในการต่อต้านภูมิแพ้และต่อต้านโรคหืด การเตรียมและใช้สารเหล่านี้

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment